Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity
暂无分享,去创建一个
C. Richart | Laia Bertran | C. Aguilar | D. Riesco | T. Auguet | S. Martínez | F. Sabench | D. Castillo | Marta Portillo-Carrasquer | Andrea Barrientos-Riosalido | Margarita Vives | Amada Culebradas
[1] R. González-Sarmiento,et al. PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy , 2021, Journal of Gastrointestinal Surgery.
[2] Chaodong Wu,et al. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease , 2021, Cells.
[3] Bin Gao,et al. Targeting adipose tissue to tackle NASH: SPARCL1 as an emerging player. , 2021, The Journal of clinical investigation.
[4] J. Vidal,et al. A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity , 2021, International journal of molecular sciences.
[5] Yuping Zhang,et al. PPARγ attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p/SFRP5 pathway , 2021, Molecular medicine reports.
[6] Anuradha Kalita,et al. The role of Wnt pathway in obesity induced inflammation and diabetes: a review , 2021, Journal of Diabetes & Metabolic Disorders.
[7] F. Bacopoulou,et al. The Emerging Role of Sfrp5 and Wnt5a in the Pathogenesis of Obesity: Implications for a Healthy Diet and Lifestyle , 2021, Nutrients.
[8] C. Richart,et al. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity , 2021, International journal of molecular sciences.
[9] Kenneth A. Philbrick,et al. Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease , 2021, Journal of clinical medicine.
[10] S. Klein,et al. Associations among adipose tissue immunology, inflammation and exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease. , 2021, Gastroenterology.
[11] N. Arfian,et al. Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. , 2021, The Medical journal of Malaysia.
[12] G. Wu,et al. Liver and serum adiponectin levels in non‐alcoholic fatty liver disease , 2021, Journal of digestive diseases.
[13] R. Nusse,et al. Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis , 2021, Frontiers in Cell and Developmental Biology.
[14] O. MacDougald,et al. Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells , 2020, Molecular metabolism.
[15] Hongliang Li,et al. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. , 2020, Free radical biology & medicine.
[16] M. Allison,et al. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. , 2020, Gastroenterology.
[17] T. Cotter,et al. NAFLD 2020: The State of the Disease. , 2020, Gastroenterology.
[18] P. Dandona,et al. Macronutrient Mediated Inflammation and Oxidative Stress: Relevance to Insulin Resistance, Obesity and Atherogenesis. , 2019, The Journal of clinical endocrinology and metabolism.
[19] Hongting Zheng,et al. Central Sfrp5 regulates hepatic glucose flux and VLDL- triglyceride secretion. , 2019, Metabolism: clinical and experimental.
[20] Y. Lecarpentier,et al. Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers , 2019, Front. Oncol..
[21] N. Borruel,et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. , 2019, Autoimmunity reviews.
[22] M. Kjaer,et al. An anti-inflammatory phenotype in visceral adipose tissue of old lean mice, augmented by exercise , 2019, Scientific Reports.
[23] S. Altay,et al. The Relationship Between Gender Differences and Abnormal Adipokine Profile for Cardiometabolic Risk Indicators , 2019, Balkan medical journal.
[24] B. Mittal. Subcutaneous adipose tissue & visceral adipose tissue , 2019, The Indian journal of medical research.
[25] Gangyi Yang,et al. Sfrp5 interacts with Slurp1 to regulate the accumulation of triglycerides in hepatocyte steatosis model. , 2019, Biochemical and biophysical research communications.
[26] M. Moreno-Aliaga,et al. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation , 2019, Nutrients.
[27] A. Nencioni,et al. Resistin: A reappraisal , 2019, Mechanisms of Ageing and Development.
[28] Y. Klimentidis,et al. The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner , 2018, PloS one.
[29] Jun Li,et al. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis. , 2018, Gene.
[30] Shuang Song,et al. Downregulation of Sfrp5 in insulin resistant rats promotes macrophage-mediated pulmonary inflammation through activation of Wnt5a/JNK1 signaling. , 2018, Biochemical and biophysical research communications.
[31] Ji-qiu Wang,et al. Wnt/β-Catenin Signaling and Obesity , 2018, Front. Physiol..
[32] B. Neuschwander‐Tetri,et al. Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.
[33] Qing Zhu,et al. The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus , 2018, Bioscience reports.
[34] L. Joosten,et al. IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies. , 2018, Trends in molecular medicine.
[35] P. Scherer,et al. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization , 2018, Molecular and Cellular Biology.
[36] K. Kowdley,et al. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. , 2018, Clinics in liver disease.
[37] W. Tian,et al. Wnt5a regulates the cell proliferation and adipogenesis via MAPK‐independent pathway in early stage of obesity , 2018, Cell biology international.
[38] C. Apovian,et al. Activation of non-canonical WNT signaling in human visceral adipose tissue contributes to local and systemic inflammation , 2017, Scientific Reports.
[39] Gangyi Yang,et al. Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults , 2017, Diabetes/metabolism research and reviews.
[40] Linuo Zhou,et al. Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis , 2017, Nutrition & Metabolism.
[41] A. Xu,et al. Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease , 2017, Chinese Journal of Integrative Medicine.
[42] Joseph M Pappachan,et al. Non-alcoholic Fatty Liver Disease: A Clinical Update , 2017, Journal of clinical and translational hepatology.
[43] L. Beilin,et al. Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults , 2017, Biology of Sex Differences.
[44] L. Beljaars,et al. RESEARCH Liver and Biliary Tract Physiology/Pathophysiology WNT-5A regulates TGF- (cid:2) -related activities in liver fibrosis , 2017 .
[45] A. Sanyal,et al. Therapies in non‐alcoholic steatohepatitis (NASH) , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[46] Shinsuke Akita,et al. Human adipocytes from the subcutaneous superficial layer have greater adipogenic potential and lower PPAR-γ DNA methylation levels than deep layer adipocytes. , 2016, American journal of physiology. Cell physiology.
[47] F. Novelli,et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. , 2016, Clinical science.
[48] C. Richart,et al. Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women , 2015, International journal of molecular sciences.
[49] Y. Kim,et al. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease , 2015, Medicine.
[50] J. Mann,et al. Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells , 2015, PloS one.
[51] C. Aguilar-Salinas,et al. SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women. , 2015, Annals of hepatology.
[52] N. Ouchi,et al. Secreted frizzled‐related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[53] M. Fasshauer,et al. Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity , 2015, PloS one.
[54] Weiqing Wang,et al. SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. , 2014, Journal of molecular endocrinology.
[55] S. Rutz,et al. The IL-20 subfamily of cytokines — from host defence to tissue homeostasis , 2014, Nature Reviews Immunology.
[56] K. Walsh,et al. Noncanonical Wnt Signaling Promotes Obesity-Induced Adipose Tissue Inflammation and Metabolic Dysfunction Independent of Adipose Tissue Expansion , 2014, Diabetes.
[57] Yanfeng Xiao,et al. SFRP5 correlates with obesity and metabolic syndrome and increases after weight loss in children , 2014, Clinical endocrinology.
[58] G. Frühbeck,et al. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. , 2014, The Journal of clinical endocrinology and metabolism.
[59] A. López-Bermejo,et al. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children , 2014, Pediatric Research.
[60] W. Ouyang,et al. Therapeutic opportunities of the IL-22–IL-22R1 system , 2013, Nature Reviews Drug Discovery.
[61] P. Scherer,et al. Tracking adipogenesis during white adipose tissue development, expansion and regeneration , 2013, Nature Medicine.
[62] J. M. Suh,et al. PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.
[63] K. Ueno,et al. The effect of sex hormones on peroxisome proliferator-activated receptor gamma expression and activity in mature adipocytes. , 2013, Biological & pharmaceutical bulletin.
[64] A. Diehl,et al. The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis. , 2013, The Journal of clinical investigation.
[65] M. Pagliassotti,et al. Metabolic alterations following visceral fat removal and expansion , 2012, Adipocyte.
[66] S. Cinti. The adipose organ at a glance , 2012, Disease Models & Mechanisms.
[67] S. Mandrup,et al. Lighting the fat furnace without SFRP5. , 2012, The Journal of clinical investigation.
[68] Hiroyuki Mori,et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. , 2012, The Journal of clinical investigation.
[69] Y. Chawla,et al. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). , 2012, Annals of hepatology.
[70] M. Laudes,et al. Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects , 2012, PloS one.
[71] D. Goulis,et al. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. , 2011, Metabolism: clinical and experimental.
[72] Yuichi Akasaki,et al. Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity , 2010, Science.
[73] A. Ayad,et al. Serum resistin levels in nonalcoholic fatty liver disease and their relationship to severity of liver disease , 2010 .
[74] C. Mantzoros,et al. Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. , 2010, European journal of endocrinology.
[75] U. Smith,et al. Activation of Canonical Wingless-type MMTV Integration Site Family (Wnt) Signaling in Mature Adipocytes Increases β-Catenin Levels and Leads to Cell Dedifferentiation and Insulin Resistance* , 2010, The Journal of Biological Chemistry.
[76] F. Karpe,et al. Gluteofemoral body fat as a determinant of metabolic health , 2010, International Journal of Obesity.
[77] D. Langin,et al. Adipokines and dietary interventions in human obesity , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[78] M. Ibrahim. Subcutaneous and visceral adipose tissue: structural and functional differences , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[79] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[80] Ichiro Takada,et al. Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis , 2009, Nature Reviews Rheumatology.
[81] W. Cawthorn,et al. Dact1, a Nutritionally Regulated Preadipocyte Gene, Controls Adipogenesis by Coordinating the Wnt/β-Catenin Signaling Network , 2009, Diabetes.
[82] Antonio Vidal-Puig,et al. Adipogenesis and WNT signalling , 2009, Trends in Endocrinology & Metabolism.
[83] M. Kasuga,et al. Diet-induced up-regulation of gene expression in adipocytes without changes in DNA methylation. , 2008, The Kobe journal of medical sciences.
[84] J. Kench,et al. Visceral fat: A key mediator of steatohepatitis in metabolic liver disease , 2008, Hepatology.
[85] A. Sonmez,et al. Adipokines and cytokines in non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.
[86] Ja-june Jang,et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis , 2008, Journal of gastroenterology and hepatology.
[87] A. Baranova,et al. Adipokines and cytokines in non‐alcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.
[88] Arya M. Sharma,et al. Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue—Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism , 2007 .
[89] S. Kersten,et al. PPARs, Obesity, and Inflammation , 2006, PPAR research.
[90] R. Kitazawa,et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.
[91] T. Mendoza,et al. Changes in Gene Expression Foreshadow Diet-Induced Obesity in Genetically Identical Mice , 2006, PLoS Genetics.
[92] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[93] C. Mantzoros,et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. , 2003, Obesity research.
[94] A. Garg,et al. Hepatic steatosis, insulin resistance, and adipose tissue disorders. , 2002, The Journal of clinical endocrinology and metabolism.
[95] H. Gin,et al. Relationship between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha gene expression in obese human adipose tissue , 2002, International Journal of Obesity.
[96] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[97] Havva Sezer,et al. Insulin Resistance, Obesity and Lipotoxicity. , 2017, Advances in experimental medicine and biology.
[98] Michael Roden,et al. NAFLD and diabetes mellitus , 2017, Nature Reviews Gastroenterology &Hepatology.
[99] Zhengai Xiong,et al. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. , 2013, The Journal of clinical endocrinology and metabolism.
[100] M. Pagliassotti,et al. 2012 Landes Bioscience. Do not distribute. Metabolic alterations following visceral fat removal and expansion Beyond anatomic location , 2012 .
[101] D. Nicholls,et al. Thermogenic mechanisms in brown fat. , 1984, Physiological reviews.